Downside play in Tower Group

A large trade is looking at the potential for more downside in insurance firm Tower Group International.

Read more »

3 Top-Ranked Precious Metals Funds to Buy

Investors often seek solace in precious metals instruments during a downturn. These investments are considered to be a natural hedge against a rapidly declining currency.

Read more »

Trading Options in New Territory with Zoetis Inc. Calls

Our options trading activities will take a new dimension today as we consider trading the options of companies involved in animal health medicines.

Read more »

106% Profit in 18 Days: United States Steel Corporation

It is another beautiful Monday morning and am I excited about the possibilities that options trading holds as we start this week on a winning note. On July 31, I wrote a piece on trading the options of U.S steel makers with a special focus on United States Steel Corporation…

Read more »

Can AvalonBay Continue Its Ride on the Growth Trajectory?

AvalonBay Communities Inc. (AVB) is riding on the growth trajectory.

Read more »

Spread Sees Coca-Cola Bubbling Up

A call spread is looking for gains in Coca-Cola by the end of summer.

Read more »

Google Moving Aggressively To Develop Its Global Location Based Services

Mountain View, Calif.-based tech mammoth Google is in the process of adding another feather to its hat.

Read more »

Nordstrom Beats on Q2 Earnings by a Penny, Narrows Guidance

Nordstrom Inc. yesterday posted yet another quarter of better-than-expected results.

Read more »

Trade sees Ironwood on solid ground

Ironwood Pharmaceuticals has been sitting at a key level, and one investor thinks support will hold.

Read more »

LinkedIn Corp: Connecting the Dots for Profits

LinkedIn Corp (NYSE:LNKD) is an interesting social media stock that has an amazing potential to reward bullish plays irrespective of the level of fear in the market.

Read more »

Nike Is Poised To Grow

NIKE has announced an increase to its fiscal 2015 revenue target to a new range of $28-30 billion, up from its previous target of $27 billion announced in May 2010.

Read more »

Intercept Pharmaceuticals Posts Earnings, Pipeline in Focus

Intercept Pharmaceuticals, Inc.’s (ICPT) shares gained 16.6% following the company’s impressive second-quarter 2014 earnings results.

Read more »